Lilly's pancreatic cancer treatment fails late-stage study
October 16, 2019 at 07:06 AM EDT
Eli Lilly and Co said on Wednesday its experimental pancreatic cancer treatment in combination with a cocktail of chemotherapies did not meet the main goal in a late-stage study.